Potassium Bicarbonate has 8 known drug interactions based on U.S. FDA drug labeling data. Of these, 1 are contraindicated combinations that should be avoided entirely. 2 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Potassium Supplements, Angiotensin Ii, Magnesium Sulfate Heptahydrate. Patients taking Potassium Bicarbonate should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 8
- Contraindicated
- 1
- Major
- 2
- Moderate
- 5
Contraindicated (1)
- Potassium Bicarbonate + Potassium Supplements— Simultaneous administration can produce severe hyperkalemia.
Major (2)
- Potassium Bicarbonate + Angiotensin Ii— Concurrent use may lead to serious hyperkalemia. Combination requires careful monitoring.
- Potassium Bicarbonate + Magnesium Sulfate Heptahydrate— Most salt substitutes contain substantial amounts of potassium; concomitant use could result in hyperkalemia.
Moderate (5)
- Potassium Bicarbonate + Digitalis Glycosides— May produce unfavorable interactions with potassium supplements, risk of hyperkalemia.
- Potassium Bicarbonate + Heparin— May produce unfavorable interactions with potassium supplements, risk of hyperkalemia.
- Potassium Bicarbonate + Mao Inhibitors— May produce unfavorable interactions with potassium supplements, risk of hyperkalemia.
- Potassium Bicarbonate + Nonselective Beta-Adrenergic Antagonists— May produce unfavorable interactions with potassium supplements, risk of hyperkalemia.
- Potassium Bicarbonate + Nsaids— May produce unfavorable interactions with potassium supplements, risk of hyperkalemia.